Aa. Elfarra et al., METHIMAZOLE PROTECTION OF RATS AGAINST GENTAMICIN-INDUCED NEPHROTOXICITY, Canadian journal of physiology and pharmacology, 72(10), 1994, pp. 1238-1244
Methimazole was previously shown to protect rats, mice, and (or) dogs
against cisplatin-, cephaloridine-, 2-bromophydroquinone-, and S-(1,2-
dichlorovinyl)-L-cysteine-induced nephrotoxicity. In this study, methi
mazole effects on gentamicin (GM) induced nephrotoxicity were examined
. Rats given GM (40 mg/kg) twice daily for 10 days exhibited higher bl
ood urea nitrogen (BUN) concentrations and severe necrosis of virtuall
y all proximal tubules compared with saline-treated controls. Rats cot
reated with methimazole (20 mg/kg) exhibited minimal proximal tubular
necrosis and were protected against GM-induced increase in BUN concent
rations, despite having higher kidney GM concentrations. Rats given GM
alone for 3 days exhibited no proximal tubular necrosis and no elevat
ion of BUN values. However, these rats exhibited an increase in nonpro
tein disulfide concentrations and a decrease in renal protein thiol an
d protein disulfide concentrations, as opposed to rats given GM and me
thimazole. Together the results show that methimazole was an effective
antagonist of GM-induced nephrotoxicity. Methimazole did not inhibit
GM renal uptake but may protect against GM-induced nephrotoxicity by a
cting as an antioxidant within the kidneys.